BioXcel Therapeutics Misses Q2 EPS by 15c QA

  • Investing.com
BioXcel Therapeutics Misses Q2 EPS by 15c QA

BioXcel Therapeutics (BTAI) reported Q2 EPS of ($1.35), $0.15 worse than the analyst estimate of ($1.20).

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or

100

Related Articles